Paul Taylor
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 10%
- Molecular Biology
- Biotechnology top 5%
- Epidemiology
- Co-authors
- Dean A. FennellAnna K. NowakArnaud ScherpereelJoachim G.J.V. AertsS. CedrésHedy L. KindlerFederica GrossoAlessandra Bearz
- Topics
- Occupational and environmental lung diseases (15 papers)Pleural and Pulmonary Diseases (9 papers)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Paul Taylor
31 papers receiving 890 citations
Hit Papers
Peers
Comparison fields: 5 of 72
- Pulmonary and Respiratory Medicine 566
- Oncology 347
- Molecular Biology 134
- Biotechnology 101
- Epidemiology 90
Countries citing papers authored by Paul Taylor
This map shows the geographic impact of Paul Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Taylor more than expected).
Fields of papers citing papers by Paul Taylor
This network shows the impact of papers produced by Paul Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Taylor. The network helps show where Paul Taylor may publish in the future.
Co-authorship network of co-authors of Paul Taylor
This figure shows the co-authorship network connecting the top 25 collaborators of Paul Taylor. A scholar is included among the top collaborators of Paul Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Taylor. Paul Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 2 | |
| 3 | 17 | |
| 4 | 85 | |
| 5 | 15 | |
| 6 | 55 | |
| 7 | 77 | |
| 8 | Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trialbreakdown → | 304 |
| 9 | 8 | |
| 10 | 3 | |
| 11 | 25 | |
| 12 | 39 | |
| 13 | 42 | |
| 14 | 2 | |
| 15 | 2 | |
| 16 | 20 | |
| 17 | 5 | |
| 18 | 23 | |
| 19 | Long-term (25-year) survival after renal homotransplantation--the world experience. | 22 |
| 20 | 4 |
About Paul Taylor
Paul Taylor is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Transplantation, having authored 32 papers that have together received 900 indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (15 papers), Pleural and Pulmonary Diseases (9 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (566 citations), Oncology (347 citations) and Biotechnology (101 citations). Paul Taylor has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Dean A. Fennell, Anna K. Nowak, Arnaud Scherpereel, Joachim G.J.V. Aerts, S. Cedrés, Hedy L. Kindler, Federica Grosso, Alessandra Bearz, Anne S. Tsao and Dariusz M. Kowalski. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.